Allen Waxman

• Served as National Counsel or Head of Litigation for multiple mass tort litigations. 
  • Established virtual law firms and led trial teams in the Norplant and Fen-Phen litigations.
  • Acted as national counsel and head of regulatory witness preparation team in the Baycol litigation.
  • Oversaw Rezulin, Neurontin and COX-2 multi-dimensional litigations, including products liability, consumer fraud and AG actions, and developed successful resolution strategies.  
  • Co-led resolution strategies for the HRT litigation and successfully executed on multiple negotiations to resolve the litigation. 
• Oversaw successful IP litigations for Lipitor and Aloxi extending the lifecycle of these significant products.
• Led commercial, manufacturing and R&D compliance diagnostics for various life sciences companies, evaluating risks and refining controls.
• Designed strategies and negotiated contracts for achieving at least parity placement for obesity, epilepsy (Part D) and oncology (Part B) medicines on formularies.
• Designed governance models for biotech company’s multiple subsidiaries to support freedom to operate within focused business areas while ensuring effective oversight.
• Developed compliance for corporate, healthcare, data privacy and security, and HR programs across biotech enterprise.
• Drove passage of “Improving Regulatory Transparency for New Medical Therapies Act,” reforming regulatory process for medicines subject to DEA scheduling.
• Led drafting of Principles, Protocols and Procedures for administration of dispute resolution at CPR Dispute Resolution Services.
• Led team of in-house and outside counsel in preparing a Manual on Mitigating Risk in Life Sciences Transactions, examining key clauses in licensing agreements and how they might better be deployed to support the goals of the transaction.
• Adopted new Diversity, Equity and Inclusion platform, known as the Ray Corollary Initiative, to drive more diverse deployment of arbitrators and mediators at CPR Dispute Resolution Services.
• Designed a protocol for resolving mass employment-related claims, which received endorsement from the United States District Court for the Northern District of California.
• Launched a Pledge for Dispute Prevention in Business Relationships, developing mechanisms to identify conflict early and address it before it becomes a costly dispute.
• Trained as an arbitrator, mediator and ombudsman.

• Co-author, "How In-House Legal Departments Should Engage with Generative AI," Bloomberg Law, September 6, 2024
• Co-author, "Dispute Prevention Strategies to Halt Strife Before It Starts," Law360 (March 27, 2023)
• Co-author, "Seizing the Benefits of Arbitration - It's in Your Hands," The American Review of International Arbitration: Columbia Law School, Vol. 22, No. 2 (January 2023)
• Co-Editor, "Mitigating Risk in Life Sciences Transactions," CPR Healthcare and Life Sciences Committee (2023)

Allen hosted “Avoiding the Dispute Before It Begins,” a series of podcasts for the ABA on dispute prevention. 

• Episode 1, "An Introduction to Dispute Prevention for Business Relationships"
• Episode 2, "Application of Dispute Prevention – Construction Projects"
• Episode 3: "Application of Dispute Prevention – Supply Chain Management"
• Episode 4: "Application of Dispute Prevention – The View from the C-Suite"
• Episode 5: "Dispute Prevention - Dispute Management Boards"
• Episode 6: "Training Dispute Prevention Professionals"